Aptorum Group (APM) stock Forecast for 2022 – 2026
Last update: 05-28-2022, 14:22Sector: Healthcare
The share price of Aptorum Group Limited (APM) now
What analysts predict:: $15
52-week high/low: $3.5 / $0.855
50/200 Day Moving Average: $1.302 / $1.904
This figure corresponds to the average price over the previous 50/200 days. For Aptorum Group stocks, the 50-day moving average is the resistance level today.
For Aptorum Group stocks, the 200-day moving average is the resistance level today.
Are you interested in Aptorum Group Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptorum Group stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aptorum Group share be worth in 2022 - 2026?
When should I take profit in Aptorum Group stock? When should I record a loss on Aptorum Group stock? What are analysts' forecasts for Aptorum Group stock? What is the future of Aptorum Group stock?
We forecast Aptorum Group stock performance using neural networks based on historical data on Aptorum Group stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aptorum Group stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aptorum Group shares. This happens once a day.
Historical and forecast chart of Aptorum Group stock
The chart below shows the historical price of Aptorum Group stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aptorum Group stock price can be found in the table below.
Long-term forecasts by years.
Aptorum Group daily forecast for a month
Aptorum Group Daily Price Targets
Aptorum Group Stock Forecast 05-30-2022.
Pessimistic target level: 1.29
Optimistic target level: 1.35
Aptorum Group Stock Forecast 05-31-2022.
Pessimistic target level: 1.26
Optimistic target level: 1.31
Aptorum Group Stock Forecast 06-01-2022.
Pessimistic target level: 1.23
Optimistic target level: 1.29
Aptorum Group Stock Forecast 06-02-2022.
Pessimistic target level: 1.26
Optimistic target level: 1.31
Aptorum Group Stock Forecast 06-03-2022.
Pessimistic target level: 1.27
Optimistic target level: 1.34
Aptorum Group Stock Forecast 06-04-2022.
Pessimistic target level: 1.30
Optimistic target level: 1.33
APM (APM) Monthly Stock Prediction for 2022
Aptorum Group forecast for this year
Aptorum Group Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $1.09536. Pessimistic: $1.05. Optimistic: $1.16
Aptorum Group Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $1.0533. Pessimistic: $0.94. Optimistic: $1.14
Aptorum Group Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $1.09037. Pessimistic: $1.04. Optimistic: $1.21
Aptorum Group Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $1.12527. Pessimistic: $0.99. Optimistic: $1.21
Aptorum Group Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $1.16488. Pessimistic: $1.06. Optimistic: $1.22
Aptorum Group Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $1.11642. Pessimistic: $1.06. Optimistic: $1.25
Aptorum Group Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $1.14142. Pessimistic: $1.05. Optimistic: $1.20
Aptorum Group (APM) Monthly Stock Prediction for 2023
Aptorum Group (APM) Monthly Stock Prediction for 2024
Aptorum Group (APM) Monthly Stock Prediction for 2025
Aptorum Group (APM) Monthly Stock Prediction for 2026
Aptorum Group information and performance
Aptorum Group Limited is a pharmaceutical company engaged in the discovery, development and commercialization of therapeutic assets for the treatment of diseases, in particular infectious diseases and oncological diseases (including indications for orphan oncology). Through the establishment of drug discovery platforms, it enables the discovery of new therapeutic assets through the systematic screening of existing approved drug molecules and a microbiome-based research platform for the treatment of metabolic diseases. In addition to this, the company also carries out therapeutic and diagnostic projects in the fields of neurology, gastroenterology, metabolic disorders, women’s health and other diseases. It also has projects focused on surgical robotics and a natural supplement for women going through menopause and experiencing symptoms associated with it.
Aptorum Group Address
17 HANOVER SQUARE, LONDON, UNITED KINGDOM
Market Capitalization: 37 483 100 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -12 622 395 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.547
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 19.72
Enterprise Value (EV) /Revenue
EV To EBITDA: 9.92
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 13260400
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.